Axonal Degeneration as a target for neuroprotection

Destruction programs are cellular mechanisms that have survival value when they operate under physiological control, but their malfunction could be deleterious for the organism. Apoptosis, or programmed cell death, is a well-known physiological destruction mechanism most apparent during development but persisting throughout the organism’s life. Other destruction programs are emerging as physiological processes that may not terminate in the destruction of the whole cell but only of restricted cellular domains. In the case of neurons, pruning of exuberant branches of terminal arborizations and degeneration of axons severed from their cell bodies are outstanding examples. Importantly, axonal degeneration is an early event in neurodegenerative condition including Alzheimer´s and Parkinson disease, as well as peripheral neuropathies. We are interested to define molecular players in the process of axonal degeneration to find therapeutic targets for neuroprotection.

Golgi staining of a mouse hippocampal section, with this technique, sparse neuronal labelling is obtained, which allows detailed analysis of individual neurons.

The degeneration of axons constitutes a salient feature shared by several neurodegenerative diseases that contributes to neuronal dysfunction and cell death. To date, the precise molecular and cellular mechanisms of axonal degeneration are under intense investigation. The morphological evidence indicates that axon degeneration as a consequence of aging and neurodegenerative diseases takes place in a retrograde fashion also known as dying back degeneration, which precedes cell death of the neuronal soma. Axon degeneration shares several characteristics with cell death by activation of the necroptotic signaling pathway, including mitochondrial dysfunction, ROS production, and intracellular calcium increase, and we have found that necroptosis inhibition by genetic or pharmacological means delays axonal degeneration in neurons from the peripheral and central nervous systems, as well as in model of Alzheimer´s and Parkinson Disease.

People involved

Macarena Arrazola

PI collaborator

PhD in Biological Sciences from the Catholic University of Chile. Studying the contribution of necroptosis in the age-associated axonal degeneration of the hippocampus, and the impact of using pharmacological approaches to revert neuronal dysfunction and cognitive impairment during aging, proposing necroptosis as an attractive target for the future development of geroprotective tools to treat age-related disabilities.

Genesis Vega

Postdoctoral fellow

Bachelor’s degree in Biochemistry at the Universidad Austral de Chile. PhD in Sciences with mention in cellular and molecular biology at the Universidad Austral de Chile carried out at CECs and University of Heidelberg. Studying the role of NAD+ imbalance in the activation of necrosome and dysfunction of mitochondrial metabolism in chemotherapy-induced axonal degeneration in aged peripheral neurons.

Related Publications

An Optimized Comparative Proteomic Approach as a Tool in Neurodegenerative Disease Research

Rachel A. Kline, Lena Lößlein, Dominic Kurian, Judit Aguilar Martí, Samantha L. Eaton,
Felipe A. Court, Thomas H. Gillingwater, and Thomas M. Wishart

Cells 202211(17), 2653;

Read More

Ex Vivo Analysis of Axonal Degeneration Using Sciatic and Optic Nerve Preparations.

López-Leal R, Court FA.

Methods Mol Biol. 2020;2143:179-189. doi: 10.1007/978-1-0716-0585-1_14.

PMID: 32524481

Read More

Insulin-like growth factor 2 (IGF2) protects against Huntington’s disease through the extracellular disposal of protein aggregates.

García-Huerta P, Troncoso-Escudero P, Wu D, Thiruvalluvan A, Cisternas-Olmedo M, Henríquez DR, Plate L, Chana-Cuevas P, Saquel C, Thielen P, Longo KA, Geddes BJ, Lederkremer GZ, Sharma N, Shenkman M, Naphade S, Sardi SP, Spichiger C, Richter HG, Court FA, Tshilenge KT, Ellerby LM, Wiseman RL, Gonzalez-Billault C, Bergink S, Vidal RL, Hetz C.

Acta Neuropathol. 2020 Nov;140(5):737-764. doi: 10.1007/s00401-020-02183-1. Epub 2020 Jul 8.

PMID: 32642868

Read More

Metformin protects from oxaliplatin induced peripheral neuropathy in rats.

Martinez NW, Sánchez A, Diaz P, Broekhuizen R, Godoy J, Mondaca S, Catenaccio A, Macanas P, Nervi B, Calvo M, Court FA.

Neurobiol Pain. 2020 May 22;8:100048. doi: 10.1016/j.ynpai.2020.100048. eCollection 2020 Aug-Dec.

PMID: 32490289

Read More

Related News

U. Mayor recibirá financiamiento para 13 nuevos proyectos Fondecyt Regular

La institución aumentó su número de proyectos seleccionados por la Agencia Nacional de Investigación y Desarrollo (ANID) más del doble con respecto al año pasado. El resultado “refleja que nuestro…

Científico advierte que la penalización de la marihuana limita las investigaciones sobre su uso medicinal

Giovanni Marsicano, académico de la Universidad de Burdeos, visitó la U. Mayor para exponer sobre el trabajo que durante las últimas décadas lo ha convertido en uno de los investigadores más…

Other Categories